Hostname: page-component-8448b6f56d-42gr6 Total loading time: 0 Render date: 2024-04-19T01:06:20.382Z Has data issue: false hasContentIssue false
  • English
  • Français

Enteric Carriage of Vancomycin-Resistant Enterococcus faecium in Patients Tested for Clostridium difficile

Published online by Cambridge University Press:  02 January 2015

Jane M. Garbutt ,
Benjamin Littenberg ,
Bradley A. Evanoff ,
Daniel Sahm  and
Linda M. Mundy
Jane M. Garbutt*
Affiliation:
Division of General Medical Sciences, Washington University School of Medicine, St Louis, Missouri
Benjamin Littenberg
Affiliation:
Division of General Medical Sciences, Washington University School of Medicine, St Louis, Missouri
Bradley A. Evanoff
Affiliation:
Division of General Medical Sciences, Washington University School of Medicine, St Louis, Missouri
Daniel Sahm
Affiliation:
Department of Pathology, Washington University School of Medicine, St Louis, Missouri
Linda M. Mundy
Affiliation:
Division of Infectious Diseases, Washington University School of Medicine, St Louis, Missouri
*
Division of General Medical Sciences, Washington University School of Medicine, Box 8005, 660 S Euclid, St Louis, MO 63110
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

To identify independent risk factors for enteric carriage of vancomycin-resistant Enterococcus faecium (VREF) in hospitalized patients tested for Clostridium difficile toxin.

Design:

Retrospective case-cohort study.

Setting:

Tertiary-care teaching hospital.

Patients:

Convenience sample of 215 adult inpatients who had stool tested for C difficile between January 29 and February 25,1996.

Results:

41 (19%) of 215 patients had enteric carriage of VREF. Five independent risk factors for enteric VREF were identified: history of prior C difficile (odds ratio [OR], 15.21; 95% confidence interval [CI95], 3.30-70.10; P<.001), parenteral treatment with vancomycin for ≥5 days (OR, 4.06; CI95, 1.54-10.73; P=.005), treatment with antimicrobials effective against gram-negative organisms (OR, 3.44; CI95, 1.20-9.87; P=.021), admission from another institution (OR, 2.95; CI95, 1.21-7.18; P=.017), and age >60 years (OR 2.57; CI95, 1.13-5.82; P=.024). These risk factors for enteric VREF were independent of the patient's current C difficile status.

Conclusions:

Antimicrobial exposures are the most important modifiable independent risk factors for enteric carriage of VREF in hospitalized patients tested for C difficile.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 20 , Issue 10 , October 1999 , pp. 664 - 670
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1999

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Uttley, AH, George, RC, Naidoo, J, Woodford, N, Johnson, AP, Collins, CH, et al. High-level vancomycin-resistant enterococci causing hospital infections. Epidemiol Infect 1989;103:173–181.Google Scholar
2. Uttley, AH, Collins, CH, Naidoo, J, George, RC. Vancomycin-resistant enterococci. Lancet 1988;1:57–58.Google Scholar
3. Sahm, DF, Kissinger, J, Gilmore, MS, Murray, PR, Mulder, R, Solliday, J, et al. In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis . Antimicrob Agents Chemother 1989;33:1588–1591.Google Scholar
4. Centers for Disease Control and Prevention. Nosocomial enterococci resistant to vancomycin—United States, 1989-1993. MMWR 1993;42:596–598.Google Scholar
5. Gaynes, R. Impact of the National Nosocomial Infections Surveillance (NNIS) System on the surveillance of nosocomial infections (N1). Presented at the Seventh Annual Meeting of the Society for Healthcare Epidemiology of America; April 27-29, 1997; St Louis, MO. Infect Control Hosp Epidemiol 1997;18(part 2):P20. Abstract 1.Google Scholar
6. Tenover, FC, Hughes, JM. The challenges of emerging infectious diseases. Development and spread of multiple-resistant bacterial pathogens. JAMA 1996;275:300–304.Google Scholar
7. Livornese, LL Jr, Dias, S, Samel, C, Romanowski, B, Taylor, S, May, P, et al. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med 1992;117:112–116.Google Scholar
8. Bonten, MJ, Hayden, MK, Nathan, C, Van Voorhis, J, Matuschek, M, Slaughter, S, et al. Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci. Lancet 1996;348:1615–1619.Google Scholar
9. Rhinehart, E, Smith, NE, Wennersten, C, Gorss, E, Freeman, J, Eliopoulos, GM, et al. Rapid dissemination of β-lactamase-producing, aminoglyco-side-resistant Enterococcus faecalis among patients and staff on an infant-toddler surgical ward. N Engl J Med 1990;323:1814–1818.Google Scholar
10. Karanfil, LV, Murphy, M, Josephson, A, Gaynes, R, Mandel, L, Hill, BC, et al. A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit Infect Control Hosp Epidemiol 1992;13:195–200.Google Scholar
11. Boyce, JM, Opal, SM, Chow, JW, Zervos, MJ, Potter-Bynoe, G, Sherman, CB, et al. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol 1994;32:1148–1153.CrossRefGoogle ScholarPubMed
12. Handwerger, S, Raucher, B, Altarac, D, Monka, J, Marcinone, S, Singh, KV, et al. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin Infect Dis 1993;16:750–755.Google Scholar
13. Smith, TL, Iwen, PC, Olson, SB, Rupp, ME. Environmental contamination with vancomycin-resistant enterococci in an outpatient setting. Infect Control Hosp Epidemiol 1998;19:515–518.CrossRefGoogle Scholar
14. Yamaguchi, E, Valena, F, Smith, SM, Simmons A, Eng, RH. Colonization pattern of vancomycin-resistant Enterococcus faecium . Am J Infect Control 1994;22:202–206.Google Scholar
15. Gordts, B, Van Landuyt, H, leven, M, Vandamme, P, Goossens, H. Vancomycin-resistant enterococci colonizing the intestinal tracts of hospitalized patients. J Clin Microbiol 1995;33:2842–2846.Google Scholar
16. Weinstein, JW, Roe, M, Towns, M, Sanders, L, Thorpe, JJ, Corey, GR, et al. Resistant enterococci: a prospective study of prevalence, incidence, and factors associated with colonization in a university hospital. Infect Control Hosp Epidemiol 1996;17:36–41.Google Scholar
17. Suppola, JP, Volin, L, Valtonen, W, Vaara, M. Overgrowth of Enterococcus faecium in the feces of patients with hematologic malignancies. Clin Infect Dis 1996;23:694–697.CrossRefGoogle ScholarPubMed
18. Morris, JG Jr, Shay, DK, Hebden, JN, McCarter, RJ Jr, Perdue, BE, Jarvis, W, et al. Enterococci resistant to multiple antimicrobial agents, including vancomycin. Establishment of endemicity in a university medical center. Ann Intern Med 1995;123:250–259.Google Scholar
19. Montecalvo, MA, Horowitz, H, Gedris, C, Carbonaro, C, Tenover, FC, Issah, A, et al. Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resis-tant Enterococcus faecium bacteremia in an adult oncology unit. Antimicrob Agents Chemother 1994;38:1363–1366.Google Scholar
20. Rubin, LG, Tucci, V, Cercenado, E, Eliopoulos, G, Isenberg, HD. Vancomycin-resistant Enterococcus faecium in hospitalized children. Infect Control Hosp Epidemiol 1992;13:700–705.Google Scholar
21. Charlson, ME, Pompei, P, Ales, KL, Mackenzie, CR A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373–383.Google Scholar
22. Rantz, LA, Kirby, WM. Enterococcic infections: an evaluation of the importance of fecal streptococci and related organisms in the causation of human disease. Arch Intern Med 1943;71:516–528.Google Scholar
23. Slaughter, S, Hayden, MK, Nathan, C, Hu, TC, Rice, T, Van Voorhis, J, et al. A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit Ann Intern Med 1996;125:448–456.Google Scholar
24. Sahm, DF, Free, L, Smith, C, Eveland, M, Mundy, LM. Rapid characterization schemes for surveillance isolates of vancomycin-resistant enterococci. J Clin Microbiol 1997;35:2026–2030.Google Scholar
25. Free, L, Sahm, DF. Detection of enterococcal vancomycin resistance by multiplex PCR. In: Persing, DH, ed. PCR Protocols for Emerging Infectious Diseases. Washington, DC: American Society of Microbiologists; 1996:150–155.Google Scholar
26. Sox, H, Blatt, MA, Higgins, MC, Marron, KI. Medical Decision Making. Stoneham, MA: Butterworth-Heinemann; 1988.Google Scholar
27. Tornieporth, NG, Roberts, RB, John, J, Hafner, A, Riley, LW. Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients. Clin Infect Dis 1996;23:767–772.Google Scholar
28. Bonilla, HF, Zervos, MA, Lyons, MJ, Bradley, SF, Hedderwick, SA, Ramsey, MA, et al. Colonization with vancomycin-resistant Enterococcus faecium: comparison of a long-term-care unit with an acute-care hospital. Infect Control Hosp Epidemiol 1997;18:333–339.Google Scholar
29. Browne, R, Fekety, R, Silva, J Jr, Boyd, DI, Work, CO, Abrams, GD. The protective effect of vancomycin on clindamycin-induced colitis in hamsters. Johns Hopkins Med J 1977;141:183–192.Google Scholar
30. Geraci, JE, Heilman, FR, Nichols, DR, Wellman, WE, Ross, GT. Some laboratory and clinical experiences with a new antibiotic, vancomycin. Staff Meetings of the Mayo Clinic 1956;31:564–582.Google ScholarPubMed
31. Rafferty, ME, McCormick, MI, Bopp, LH, Baltch, AL, George, M, Smith, RP, et al. Vancomycin-resistant enterococci in stool specimens submitted for Clostridium difficile assay. Infect Control Hosp Epidemiol 1997;18:342–344.Google Scholar
32. Lam, S, Singer, C, Tucci, V, Morthland, VH, Pfaller, MA, Isenberg, HD. The challenge of vancomycin-resistant enterococci: a clinical and epidemiological study. Am J Infect Control 1995;23:170–180.Google Scholar
33. Hacek, DM, Noskin, GA, Zembower, T, Bednarz, P, Peterson, LR Yield of vancomycin resistant enterococci and Enterobacteriaceae extended spectrum β-lactamase from stool submitted for C difficile detection compared to an ongoing surveillance program for these pathogens that is directed at high risk units. Presented at the 98th General Meeting of the American Society for Microbiology; May 17-21, 1998; Atlanta, GA. Abstract C-240.Google Scholar
34. Gerding, DN, Johnson, S, Peterson, LR, Mulligan, ME, Silva, J Jr. Clostridium difficile-associated diarrhea and colitis. Infect Control Hosp Epidemiol 1995;16:459–477.CrossRefGoogle ScholarPubMed
35. Garrison, T, Traynor, P, Windus, D, Lu, S, Bulliner, C, Mundy, L. Independent risks for vancomycin-resistant Enterococcus faecium in hemodialysis patients. Presented at the Eighth Annual Meeting of the Society for Hospital Epidemiology of America; April 5-7,1998; Orlando, FL. Infect Control Hosp Epidemiol 1998;19:683. Abstract 14.Google Scholar
36. Traynor, P, Trovillion, E, Dorris, J, Fraser, V, Sahm, D, Mundy, L. Surveillance for enteric vancomycin-resistant Enterococcus faecium (VREF) acquisition in a university hospital. Presented at the 24th Annual Meeting of the Association for Professionals in Infection Control and Epidemiology. June 1997. Am J Infect Control 1997;25:125–188. Abstract M17.Google Scholar
37. Kahn, MG, Steib, SA, Dunagan, WC, Fraser, VJ. Monitoring expert system performance using continuous user feedback. J Am Med Inform Assoc 1996;3:216–223.Google Scholar
38. Kahn, MG, Bailey, TC, Steib, SA, Fraser, VJ, Dunagan, WC. Statistical process control methods for expert system performance monitoring. J Am Med Inform Assoc 1996;3:257–268.Google Scholar
39. Feinstein, AR. Multivariable Analysis: An Introduction. New Haven, CT: Yale University Press; 1996.Google Scholar